Mimetogen Pharmaceuticals - Articles and news items

Allergan and Mimetogen to develop tavilermide for dry eye disease

Industry news / 4 November 2015 / Victoria White

Tavilermide is differentiated from other investigational therapies in dry eye disease because it induces the production of mucin…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+